Login   |  Users Online: 304 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts
PHARMACEUTICAL STANDARDIZATION
Year : 2015  |  Volume : 36  |  Issue : 1  |  Page : 83-90

Accelerated stability studies of Sufoofe Sailan: A Unani formulation


Department of Ilmul Saidla, National Institute of Unani Medicine, Bengaluru, Karnataka, India

Correspondence Address:
Seema Rani
Department of Ilmul Saidla, National Institute of Unani Medicine, Kottegepalya, Magadi Main Road, Bengaluru - 560 091, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.169007

Rights and Permissions

Introduction: Sufoofe Sailan (SS) is a polyherbal powder preparation used in Unani medicine to treat gynecological diseases. It is observed that SS degrade early as it is in the form of powder; however, the stability study of SS was not carried out till date. Aim: To evaluate the accelerated stability of SS. Materials and Methods: Finished formulation of SS was packed in three airtight transparent polyethylene terephthalate containers. One pack was analyzed just after manufacturing and remaining two packs were kept in stability chamber at 40°C ± 2°C/75% ± 5% RH, of which one pack was analyzed after the completion of three and another after 6 months. Organoleptic, physico-chemical, microbiological parameters along with high-performance thin layer chromatography (HPTLC) fingerprinting were carried out. Results: Organoleptic characters showed no significant change in accelerated stability condition. All physico-chemical parameters showed changes <5%, HPTLC fingerprinting showed minimum changes and microbial studies were in confirmation to the World Health Organization guidelines. Conclusion: SS confirmed to the International Conference on Harmonization Guideline for accelerated testing of the pharmaceutical product on said parameters and as per the Grimm's statement the shelf life of SS may last 20 months.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3766    
    Printed31    
    Emailed0    
    PDF Downloaded268    
    Comments [Add]    
    Cited by others 2    

Recommend this journal